Immutep Limited Cash and Cash Equivalents 2011-2025 | IMMP

Annual Cash and Cash Equivalents Immutep Limited

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
67.4 M	162 M	123 M	80 M	60.6 M	26.3 M	16.6 M	23.5 M	12.2 M	20.9 M	-	-	-	-	-

All numbers in AUD currency

Indicator range from annual reports

Maximum	Minimum	Average
162 M	12.2 M	59.3 M

Quarterly Cash and Cash Equivalents Immutep Limited

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	60.6 M	-	-	-	26.3 M	-	-	-	16.6 M	-	-	-	23.5 M	-	-	-	12.2 M	-	-	-	20.9 M	-	-	-	6.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in AUD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
60.6 M	6.76 M	23.8 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Ascendis Pharma A/S ASND	560 M	$ 220.27	4.81 %	$ 5 B	Danmark
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 0.28	-2.28 %	$ 609 M	Israel
Alterity Therapeutics Limited ATHE	34.8 M	$ 3.3	-3.51 %	$ 7.94 B	Australia
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Aptorum Group Limited APM	3.5 M	$ 1.29	-3.01 %	$ 7.03 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
Arbutus Biopharma Corporation ABUS	26.3 M	$ 4.75	1.61 %	$ 788 M	Canada
Aclaris Therapeutics ACRS	24.6 M	$ 3.26	-3.12 %	$ 252 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	144 M	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	89.4 M	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	248 M	-	-0.23 %	$ 916 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Amphastar Pharmaceuticals AMPH	152 M	$ 25.27	-2.43 %	$ 1.22 B	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Anika Therapeutics ANIK	72.9 M	$ 9.57	0.84 %	$ 140 M	USA
BioNTech SE BNTX	9.76 B	$ 94.73	-1.32 %	$ 27.2 B	Germany
Arena Pharmaceuticals ARNA	220 M	-	-6.81 %	$ 3.04 B	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Avenue Therapeutics ATXI	2.59 M	-	-52.27 %	$ 4.45 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Axon Enterprise AXON	455 M	$ 566.18	-2.56 %	$ 42.9 B	USA
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Aytu BioScience AYTU	31 M	$ 2.34	2.59 %	$ 14.7 M	USA
AstraZeneca PLC AZN	5.49 B	$ 89.78	-0.57 %	$ 96.9 B	Britain
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
Brickell Biotech BBI	10.9 M	-	-5.38 %	$ 6.06 M	USA
Burford Capital Limited BUR	322 M	$ 9.09	-0.55 %	$ 1.5 B	Britain
BeiGene, Ltd. BGNE	2.63 B	-	0.49 %	$ 251 B	Cayman-islands
Biohaven Pharmaceutical Holding Company Ltd. BHVN	172 M	$ 11.54	0.87 %	$ 746 M	USA
Biogen BIIB	2.38 B	$ 174.42	1.11 %	$ 25.4 B	USA
BioVie BIVI	17.5 M	$ 1.42	-5.96 %	$ 2.1 M	USA
Abeona Therapeutics ABEO	14.5 M	$ 5.36	-2.99 %	$ 115 M	USA
Dynavax Technologies Corporation DVAX	95.9 M	$ 10.85	-0.14 %	$ 1.41 B	USA
ADiTx Therapeutics ADTX	833 K	$ 2.3	-3.0 %	$ 30.3 K	USA
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
BioLineRx Ltd. BLRX	10.4 M	$ 3.17	-1.86 %	$ 908 M	Israel
bluebird bio BLUE	222 M	-	-	$ 546 M	USA